PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

Clinical pharmacy performance indicators skew to process, lack validation

clinical pharmacykey performance indicatorsquality indicatorshospital pharmacysystematic reviewAIRE instrumentDonabedian modelmedication reconciliationpatient outcomesbenchmarking Clinical Pharmacy Practice

Background Information

Hospital pharmacy KPIs lack validation and benchmark standards.

Key performance indicators (KPIs) are essential for measuring and improving the quality of clinical pharmacy services in hospital settings. Out of 13 studies developing 225 KPIs, only 5 scored over 50% on quality using the Appraisal of Indicators through Research and Evaluation (AIRE) instrument. The majority of KPIs are process-focused with limited scientific evidence and lack benchmarking, highlighting a need for improved KPI development. Current KPIs for hospital pharmacy lack validation and benchmarking, limiting their utility in quality improvement.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Magedanz L, Silva HL, Galato D, Fernandez-Llimos F

Citation: Magedanz L, Silva HL, Galato D, et al. Clinical pharmacy key performance indicators for hospital inpatient setting: a systematic review. International journal of clinical pharmacy. 2024;46(3):602-613. doi:10.1007/s11096-024-01717-x

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →